Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-04

Clinical Trial Update: Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol [Phase 4]

View source ↗

Summary

This document describes a Phase 4 study protocol assessing empagliflozin in elderly adults with type 2 diabetes, in combination with a Mediterranean diet and ci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Diabetes Mellitus, Type 2, Sarcopenia | Phase 4 | Status: COMPLETED